INVESTORS
2020-03-27MMMM D, YYYY

IR call: Sanofi expands collaboration with Translate Bio to develop mRNA COVID-19 vaccine

At a glance

Jean-Baptiste de Chatillon
2020-04-28MMMM D, YYYY

Annual General Meeting 2020: latest updates

In view of the current Covid-19 (coronavirus) pandemic in France and around the world, Sanofi's Board of Directors has decided to hold its Annual General Meeting convened on Tuesday, April 28 at 2:30 pm, without the physical presence of shareholders and with an unchanged agenda.

Upcoming events

Two young girls

2019 Integrated Report

Paul Hudson
INVESTORS

Sanofi Conference Call

2020-02-24MMMM D, YYYY

In-depth reading

Annual Report on Form 20-F 2018

Annual Report on Form 20-F 2019

Scientist
INVESTOR PRESENTATIONS

Capital Markets Day

2019-12-10MMMM D, YYYY
All financial results going back to 2013
FINANCIAL RESULTS

All financial results going back to 2015

Contact the Investor Relations team

54 rue La Boétie
75008 Paris FRANCE
France +33 (0)1 53 77 45 45 • ir@sanofi.com
United States +1 908 981 5560

Individual shareholders

Direct access to Individual shareholders - Welcome to Sanofi

Access your dedicated section

Shareholder Handbook 2019

Two Asian women

Letter to shareholders April 2020

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK